Panel Discussion Participants
Angel V. Delgado – Medtronic
Angel V. Delgado, PhD, is the Associate Director, Clinical Sciences & Strategy at Medtronic Neurovascular. In his last position Dr. Delgado was the Sr. Director of Global Medical Affairs for ConvaTec, and held leadership positions within R&D, clinical and medical Affairs at Acelity, KCI, LifeCell, Systagenix, and ArjoHuntleigh. He has conducted research in cellular biology, pharmacology, immunology/virology, and trauma & critical care and has received numerous awards and honors. He received his doctorate in Neuroscience from the University of Texas and his clinical training from the US Army Medical and Special Operations Commands.
Nakisha Holder – Johns Hopkins Technology Ventures
Nakisha Holder is an Associate Director of Licensing at Johns Hopkins Technology Ventures (JHTV) focusing on life science technologies. In this capacity she manages a team of licensing and intellectual property managers focused on evaluating, patenting, and commercializing JHU inventions. She also manages a large portfolio of diagnostic and therapeutic technologies with a goal of marketing, negotiating and executing licenses toward the development of products that will bring the benefit of JHU discoveries to the world. Nakisha has a PhD from JHU, is a Certified Licensing Professional (CLP), and is a patent agent with over 12 years of technology transfer experience.
John Janik – Stryker
John Janik has a long history of working with universities. He has negotiated and managed sponsored research agreements and has been a board member/advisor to medtech early-stage companies. John has been a visiting scholar at the University of Michigan and a member of the oversight committee. He is a mentor in the Stanford Ignite program. He is also an advisor for Zoic Capital, the Milwaukee School of Engineering Industrial Advisory Committee, Portela Soni Medical LLC and a member of the board of directors with Avegant. John holds a PhD in biomedical engineering and a PhD from Marquette University, PhD in Neuroscience from the Medical College of Wisconsin.
Cheryl Marr – John Hopkins Technology Ventures
Cheryl Marr is a Business Development Associate on the Corporate Partnerships team at Johns Hopkins Technology Ventures (JHTV). In this role, she facilitates in identifying potential corporate partners as well as identifying the right faculty investigators for those partnerships. She also serves as Alliance Manager, where she aids in negotiating and executing sponsored research contracts, managing contract deliverables and being the lead liaison between JHU faculty and corporate partners. Cheryl obtained her PhD from Vanderbilt University in Biochemistry and Structural Biology.
Vinit Nijhawan – The Massachusetts Technology Transfer Center
Vinit Nijhawan is a strategic visionary who has conceived and built several technology organizations that have been acquired by companies such as Boeing, Motorola and Qualcomm. He has worked in many industries, including computing, aerospace, logistics, supply chain, manufacturing, telecommunications, medical devices, biopharma, synthetic biology and advanced materials. Vinit began teaching entrepreneurship at Boston University and subsequently led tits Office of Technology Development from 2010-2016. Most recently, Vinit is the Interim Executive Director of the Massachusetts Technology Transfer Center and Massachusetts Association of Technology Transfer Office.
Sarah Parker – Wilson Sonsini Goodrich & Rosati
Sarah Parker is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where she is a member of the technology transactions practice. Sarah's practice focuses on life sciences companies, with an emphasis on biopharmaceutical and biotechnology companies, in transactions related to the discovery, development, supply, and commercialization of their products and technologies. Sarah regularly counsels clients in complex partnering and licensing arrangements, mergers, acquisitions, divestitures and spinouts.
Partnering Segment Companies
Boston Scientific – Mark Boden
Mark is a Senior Fellow in the Corporate Research Division of Boston Scientific. At Boston Scientific, he has worked in the fields of interventional cardiology, peripheral vascular, urology, women’s health, and endoscopy. His current activities include tech scouting, establishing and maintaining university partnerships, managing exploratory projects, and membership on several university and government advisory boards of interest to Boston Scientific. Prior, Mark worked on development and manufacturing of biosensors. He has a dual PhD from UMass Lowell in polymer chemistry and plastics engineering and specializes in biomaterials, drug/device combination products and early stage research into disease states.
Conformis, Inc. – Emmanuel Nyakako
Emmanuel Nyakako is Senior Vice President-Quality & Regulatory Affairs at Conformis, Inc. He previously was Senior VP-Global Quality, Clinical & Regulatory Affairs at Zimmer Biomet Holdings, Inc. Senior VP-Global Quality & Regulatory Affairs at Zimmer, Inc, and VP of Quality and Regulatory Affairs at Flextronics Inc. He received his MS graduate degree from Montclair State University.
Dexcom – Mark Wieczorek
Mark Wieczorek is a Partner Attorney at Dexcom, a San Diego medical device company. He has experience in all phases of IP development, including patent prosecution, strategy and analysis, and portfolio development and management. He has prepared and prosecuted patents involving circuits/devices; semiconductor materials, devices and fabrication; devices in medical diagnosis and treatment; computer hardware and software; wireless devices and systems. He advises individuals, start-up companies, universities & research institutes, and large technology and manufacturing companies. In 1998, he became Director of IP & Corporate Counsel for Innercool Therapies, an early-stage medical device company. Mark has a JD from the George Washington University Law School, and an MA and PhD in physics from Johns Hopkins University.
Edwards Lifesciences – Virginia Giddings
Virginia is Senior Director of Exploration at Edwards Lifesciences, where she advances breakthrough innovation for structural heart disease patients by building deep partnerships globally. Virginia has over 25 years’ successful experience delivering innovation to patients, with roles spanning medical device, pharmaceutical and nutrition businesses. Prior to joining Edwards, Virginia was Vice President of Innovation for IntersectENT, where she led R&D and Clinical. Throughout her career, Virginia has focused on advancing breakthrough innovation, with R&D, Program Management, and Business Development leadership roles at Stryker Neurovascular, Abbott, and Johnson & Johnson. She serves on the Cornell Engineering and Biomedical Engineering Councils, the President’s Council of Cornell Women, as well as the Georgia Tech-Emory Bioengineering Board. She is a Fellow of the American Institute of Medical and Biological Engineering and a registered Patent Agent. Virginia is a co-founder of the MedtechVision Conference, now held annually in Silicon Valley. She holds a M.Eng. degree in Mechanical Engineering from Cornell University and a PhD in Mechanical Engineering from Stanford University.
Hillrom – Eric Agdeppa
Dr. Eric Agdeppa focuses on molecular imaging of a variety of diseases and other modalities for sensing critical patient parameters for early and effective care. He leads Hillrom’s efforts to develop new, game-changing technologies through internal development efforts and relationships with academic and strategic corporate partners. As the Executive Director of Innovation and part of Hillrom’s R&D Leadership Team, he leads two innovation groups (the Early Innovation and Global Technology Integration organizations) and one data science team that accelerate the company’s innovation efforts and drive value-added technologies into future healthcare products. Dr. Agdeppa is also the General Manager of Hillrom’s first incubated, intrapreneurial start-up. Dr. Agdeppa received his Masters in Technology Management from Stevens Institute of Technology, and his PhD in biomedical physics with a specialization in biophysics/nuclear medicine also at UCLA.
HOYA – James Kaiser
James Kaiser is the Strategist for HOYA’s Corporate VC Group and the only member based outside Japan. He is the Director of Venture Capital at HOYA with a pharmaceutical research background. Has worked in fortune 500 pharmaceutical corporations, academic institutions and small start-up companies. His responsibilities include investing in start-up companies to expand HOYA’s areas of interest within the Life Care segment.
Medtronic – Angel Delgado
(see bio above)
Nihon Kohden Innovation Center - Steve Weisner
Steve Weisner is President & CEO of the Nihon Kohden Innovation Center (NKIC), which engages universities and hospitals in collaborative early stage research in medical devices. He has held leadership roles at medical device start-up companies: Reflectance Medical and Radianse and at large companies: HP Medical, Philips Medical and Draeger Medical. Steve has been responsible for business development, strategic planning, partnership management, clinical applications, product requirements, clinical trials, research, software/hardware engineering and regulatory medical device submissions. His current focus is in directed therapy, big data analytics and wearable medical devices.
Quidel – Edward Russell
Edward K. Russell joined Quidel's in 2015. Previously, he was with Life Technologies/Thermo Fisher where he was responsible for leading the North American Commercial team, a $1B operation. Mr. Russell's industry experience includes senior leadership roles at Fedex Kinko’s and Mobil Oil. He holds an MBA from the Wharton School of Business, University of Pennsylvania.
Stryker – John Janik
(see bio above)
Wilson Sonsini Goodrich & Rosati – Sarah Parker
(see bio above)